Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

The case for a population standardized infection ratio (SIR): A metric that marries the device SIR to the standardized utilization ratio (SUR).

Fakih MG, Huang RH, Bufalino A, Erlinger T, Sturm L, Hendrich A, Haydar Z.

Infect Control Hosp Epidemiol. 2019 Jun 24:1-4. doi: 10.1017/ice.2019.175. [Epub ahead of print]

PMID:
31232260
2.

Root growth and force chains in a granular soil.

Fakih M, Delenne JY, Radjai F, Fourcaud T.

Phys Rev E. 2019 Apr;99(4-1):042903. doi: 10.1103/PhysRevE.99.042903.

PMID:
31108586
3.

Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.

Parikh AR, He Y, Hong TS, Corcoran RB, Clark JW, Ryan DP, Zou L, Ting DT, Catenacci DV, Chao J, Fakih M, Klempner SJ, Ross JS, Frampton GM, Miller VA, Ali SM, Schrock AB.

Oncologist. 2019 Apr 30. pii: theoncologist.2019-0034. doi: 10.1634/theoncologist.2019-0034. [Epub ahead of print]

PMID:
31040255
4.

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.

Schrock AB, Ouyang C, Sandhu J, Sokol E, Jin D, Ross JS, Miller VA, Lim D, Amanam I, Chao J, Catenacci D, Cho M, Braiteh F, Klempner SJ, Ali SM, Fakih M.

Ann Oncol. 2019 Apr 30. pii: mdz134. doi: 10.1093/annonc/mdz134. [Epub ahead of print]

PMID:
31038663
5.

Diagnosis of urinary tract infections: need for a reflective rather than reflexive approach.

Fakih MG, Advani SD, Vaughn VM.

Infect Control Hosp Epidemiol. 2019 Jul;40(7):834-835. doi: 10.1017/ice.2019.98. Epub 2019 Apr 29. No abstract available.

PMID:
31030695
6.

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.

Eng C, Kim TW, Bendell J, Argilés G, Tebbutt NC, Di Bartolomeo M, Falcone A, Fakih M, Kozloff M, Segal NH, Sobrero A, Yan Y, Chang I, Uyei A, Roberts L, Ciardiello F; IMblaze370 Investigators.

Lancet Oncol. 2019 Jun;20(6):849-861. doi: 10.1016/S1470-2045(19)30027-0. Epub 2019 Apr 16. Erratum in: Lancet Oncol. 2019 Jun;20(6):e293.

PMID:
31003911
7.

The evolution of catheter-associated urinary tract infection (CAUTI): Is it time for more inclusive metrics?

Advani SD, Fakih MG.

Infect Control Hosp Epidemiol. 2019 Jun;40(6):681-685. doi: 10.1017/ice.2019.43. Epub 2019 Mar 27.

PMID:
30915925
8.

Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study.

Van Cutsem E, Huijberts S, Grothey A, Yaeger R, Cuyle PJ, Elez E, Fakih M, Montagut C, Peeters M, Yoshino T, Wasan H, Desai J, Ciardiello F, Gollerkeri A, Christy-Bittel J, Maharry K, Sandor V, Schellens JHM, Kopetz S, Tabernero J.

J Clin Oncol. 2019 Jun 10;37(17):1460-1469. doi: 10.1200/JCO.18.02459. Epub 2019 Mar 20.

PMID:
30892987
9.

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.

Meric-Bernstam F, Hurwitz H, Raghav KPS, McWilliams RR, Fakih M, VanderWalde A, Swanton C, Kurzrock R, Burris H, Sweeney C, Bose R, Spigel DR, Beattie MS, Blotner S, Stone A, Schulze K, Cuchelkar V, Hainsworth J.

Lancet Oncol. 2019 Apr;20(4):518-530. doi: 10.1016/S1470-2045(18)30904-5. Epub 2019 Mar 8.

PMID:
30857956
10.

Systemic treatment for metastatic colorectal cancer in the era of precision medicine.

Sandhu J, Lavingia V, Fakih M.

J Surg Oncol. 2019 Apr;119(5):564-582. doi: 10.1002/jso.25421. Epub 2019 Feb 25. Review.

PMID:
30802315
11.
12.

A Pilot Study of Vinorelbine Safety and Pharmacokinetics in Patients with Varying Degrees of Liver Dysfunction.

Gong J, Cho M, Gupta R, Synold TW, Frankel P, Ruel C, Fakih M, Chung V, Lim D, Chao J.

Oncologist. 2019 Feb 1. pii: theoncologist.2018-0336. doi: 10.1634/theoncologist.2018-0336. [Epub ahead of print]

PMID:
30710067
13.

Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme.

Li YJ, Du L, Wang J, Vega R, Lee TD, Miao Y, Aldana-Masangkay G, Samuels ER, Li B, Ouyang SX, Colayco SA, Bobkova EV, Divlianska DB, Sergienko E, Chung TDY, Fakih M, Chen Y.

Cell Chem Biol. 2019 Feb 21;26(2):278-288.e6. doi: 10.1016/j.chembiol.2018.10.026. Epub 2018 Dec 20.

PMID:
30581133
14.

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105.

Drilon A, Fu S, Patel MR, Fakih M, Wang D, Olszanski AJ, Morgensztern D, Liu SV, Cho BC, Bazhenova L, Rodriguez CP, Doebele RC, Wozniak A, Reckamp KL, Seery T, Nikolinakos P, Hu Z, Oliver JW, Trone D, McArthur K, Patel R, Multani PS, Ahn MJ.

Cancer Discov. 2019 Mar;9(3):384-395. doi: 10.1158/2159-8290.CD-18-0839. Epub 2018 Nov 28.

PMID:
30487236
15.

Clinching the cause: A review of foot drop secondary to lumbar degenerative diseases.

Macki M, Lim S, Elmenini J, Fakih M, Chang V.

J Neurol Sci. 2018 Dec 15;395:126-130. doi: 10.1016/j.jns.2018.09.036. Epub 2018 Oct 1. Review.

PMID:
30316068
16.

Culturing practices and the care of the urinary catheter in reducing NHSN-defined catheter-associated urinary tract infections: The tale of two teaching hospitals.

Bardossy AC, Williams T, Jones K, Szpunar S, Zervos M, Alangaden G, Reyes K, Fakih MG.

Infect Control Hosp Epidemiol. 2018 Dec;39(12):1494-1496. doi: 10.1017/ice.2018.251. Epub 2018 Oct 10.

PMID:
30303048
17.

Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition.

Fabrizio DA, George TJ Jr, Dunne RF, Frampton G, Sun J, Gowen K, Kennedy M, Greenbowe J, Schrock AB, Hezel AF, Ross JS, Stephens PJ, Ali SM, Miller VA, Fakih M, Klempner SJ.

J Gastrointest Oncol. 2018 Aug;9(4):610-617. doi: 10.21037/jgo.2018.05.06.

18.

The Impact of Different Postgraduate Year Training in Neurosurgery Residency on 30-Day Postoperative Outcomes.

Macki M, Fakih M, Rubinfeld I, Chang V, Walters BC.

Neurosurgery. 2019 Mar 1;84(3):778-787. doi: 10.1093/neuros/nyy277.

PMID:
30010937
19.
20.

Value-based genomics.

Gong J, Pan K, Fakih M, Pal S, Salgia R.

Oncotarget. 2018 Jan 30;9(21):15792-15815. doi: 10.18632/oncotarget.24353. eCollection 2018 Mar 20. Review.

21.

Antimicrobial stewardship and infection prevention-leveraging the synergy: A position paper update.

Manning ML, Septimus EJ, Ashley ESD, Cosgrove SE, Fakih MG, Schweon SJ, Myers FE, Moody JA.

Am J Infect Control. 2018 Apr;46(4):364-368. doi: 10.1016/j.ajic.2018.01.001. No abstract available.

PMID:
29592832
22.

Antimicrobial Stewardship and Infection Prevention-Leveraging the Synergy: A Position Paper Update.

Manning ML, Septimus EJ, Ashley ESD, Cosgrove SE, Fakih MG, Schweon SJ, Myers FE, Moody JA.

Infect Control Hosp Epidemiol. 2018 Apr;39(4):467-472. doi: 10.1017/ice.2018.33. No abstract available.

PMID:
29576043
23.

Rationale, development, and design of the Altering Intake, Managing Symptoms (AIMS) dietary intervention for bowel dysfunction in rectal cancer survivors.

Sun V, Crane TE, Slack SD, Yung A, Wright S, Sentovich S, Melstrom K, Fakih M, Krouse RS, Thomson CA.

Contemp Clin Trials. 2018 May;68:61-66. doi: 10.1016/j.cct.2018.03.010. Epub 2018 Mar 19.

24.

The Impact of Different Postgraduate Year Training in Neurosurgery Residency on 30-Day Return to Operating Room: A National Surgical Quality Improvement Program Study.

Macki M, Fakih M, Kandagatla P, Rubinfeld I, Chang V.

World Neurosurg. 2018 Jun;114:e70-e76. doi: 10.1016/j.wneu.2018.02.068. Epub 2018 Feb 21.

PMID:
29476999
25.

Hospital-Onset Staphylococcus aureus Bacteremia Is A Better Measure Than MRSA Bacteremia for Assessing Infection Prevention: Evaluation of 50 US Hospitals.

Fakih MG, Battjes R, Sturm L, Jones L, Groves C, Bufalino A, Hendrich A.

Infect Control Hosp Epidemiol. 2018 Apr;39(4):476-478. doi: 10.1017/ice.2018.13. Epub 2018 Feb 12.

PMID:
29429428
26.

Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.

Ross JS, Fakih M, Ali SM, Elvin JA, Schrock AB, Suh J, Vergilio JA, Ramkissoon S, Severson E, Daniel S, Fabrizio D, Frampton G, Sun J, Miller VA, Stephens PJ, Gay LM.

Cancer. 2018 Apr 1;124(7):1358-1373. doi: 10.1002/cncr.31125. Epub 2018 Jan 16.

27.

"I Never Would Have Caught That Before": Pharmacist Perceptions of Using Clinical Decision Support for Antimicrobial Stewardship in the United States.

Giuliano CA, Binienda J, Kale-Pradhan PB, Fakih MG.

Qual Health Res. 2018 Apr;28(5):745-755. doi: 10.1177/1049732317750863. Epub 2018 Jan 15.

PMID:
29334865
28.

Trastuzumab Plus Pertuzumab Resistance Does Not Preclude Response to Lapatinib Plus Trastuzumab in HER2-Amplified Colorectal Cancer.

Fakih MG.

Oncologist. 2018 Apr;23(4):474-477. doi: 10.1634/theoncologist.2017-0436. Epub 2018 Jan 12.

29.

Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.

Kennedy A, Brown DB, Feilchenfeldt J, Marshall J, Wasan H, Fakih M, Gibbs P, Knuth A, Sangro B, Soulen MC, Pittari G, Sharma RA.

J Gastrointest Oncol. 2017 Dec;8(6):1079-1099. doi: 10.21037/jgo.2017.09.10. Review.

30.

Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer.

Chao J, Lin J, Frankel P, Clark AJ, Wiley DT, Garmey E, Fakih M, Lim D, Chung V, Luevanos E, Eliasof S, Davis ME, Yen Y.

J Gastrointest Oncol. 2017 Dec;8(6):962-969. doi: 10.21037/jgo.2017.08.10.

31.

Reducing Inappropriate Urinary Catheter Use in the Emergency Department: Comparing Two Collaborative Structures.

Greene MT, Fakih MG, Watson SR, Ratz D, Saint S.

Infect Control Hosp Epidemiol. 2018 Jan;39(1):77-84. doi: 10.1017/ice.2017.256. Epub 2017 Dec 18.

32.

A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy.

Cho M, Gong J, Frankel P, Synold TW, Lim D, Chung V, Chao J, Li D, Chen Y, Sentovich S, Melstrom K, Singh G, Luevanos E, Fakih M.

Oncotarget. 2017 Jul 18;8(45):79750-79760. doi: 10.18632/oncotarget.19336. eCollection 2017 Oct 3.

33.

A single institute retrospective trial of concurrent chemotherapy with SIR-Spheres® versus SIR-Spheres® alone in chemotherapy-resistant colorectal cancer liver metastases.

Cho M, Kessler J, Park JJ, Lee A, Gong J, Singh G, Chen YJ, Ituarte PHG, Fakih M.

J Gastrointest Oncol. 2017 Aug;8(4):608-613. doi: 10.21037/jgo.2017.03.15.

34.

The International Duration Evaluation of Adjuvant Chemotherapy study: implications for clinical practice.

Fakih M.

J Gastrointest Oncol. 2017 Aug;8(4):603-607. doi: 10.21037/jgo.2017.07.08. No abstract available.

35.

Empowering survivors after colorectal and lung cancer treatment: Pilot study of a Self-Management Survivorship Care Planning intervention.

Reb A, Ruel N, Fakih M, Lai L, Salgia R, Ferrell B, Sampath S, Kim JY, Raz DJ, Sun V.

Eur J Oncol Nurs. 2017 Aug;29:125-134. doi: 10.1016/j.ejon.2017.06.003. Epub 2017 Jun 19.

36.

MEK162 Enhances Antitumor Activity of 5-Fluorouracil and Trifluridine in KRAS-mutated Human Colorectal Cancer Cell Lines.

Gong J, Chen Y, Yang L, Pillai R, Shirasawa S, Fakih M.

Anticancer Res. 2017 Jun;37(6):2831-2838.

PMID:
28551618
37.

Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function.

Gong J, Cho M, Fakih M.

J Gastrointest Oncol. 2017 Apr;8(2):314-323. doi: 10.21037/jgo.2016.09.17. Review.

38.

Definitional Change in NHSN CAUTI Was Associated with an Increase in CLABSI Events: Evaluation of a Large Health System.

Fakih MG, Groves C, Bufalino A, Sturm LK, Hendrich AL.

Infect Control Hosp Epidemiol. 2017 Jun;38(6):685-689. doi: 10.1017/ice.2017.41. Epub 2017 Mar 23.

PMID:
28330520
39.

Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring a POLE Mutation.

Gong J, Wang C, Lee PP, Chu P, Fakih M.

J Natl Compr Canc Netw. 2017 Feb;15(2):142-147.

PMID:
28188185
40.

Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience.

Gong J, Cho M, Sy M, Salgia R, Fakih M.

Oncotarget. 2017 Jun 27;8(26):42198-42213. doi: 10.18632/oncotarget.15030.

41.
42.

Improving the Culture of Culturing: Critical Asset to Antimicrobial Stewardship.

Fakih MG, Khatib R.

Infect Control Hosp Epidemiol. 2017 Mar;38(3):377-379. doi: 10.1017/ice.2016.319. Epub 2016 Dec 29. No abstract available.

PMID:
28031074
43.

Health Systems Can Play a Pivotal Role in Supporting Antimicrobial Stewardship.

Fakih MG, Guharoy R, Hendrich A, Haydar Z.

Clin Infect Dis. 2016 Nov 15;63(10):1391. Epub 2016 Aug 30. No abstract available.

PMID:
27578817
44.

Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.

Hall MD, Schultheiss TE, Smith DD, Fakih MG, Wong JY, Chen YJ.

Acta Oncol. 2016 Dec;55(12):1392-1399. Epub 2016 Oct 20.

PMID:
27762654
45.

RAS and BRAF in metastatic colorectal cancer management.

Gong J, Cho M, Fakih M.

J Gastrointest Oncol. 2016 Oct;7(5):687-704. Review.

46.

Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer.

Rankin A, Klempner SJ, Erlich R, Sun JX, Grothey A, Fakih M, George TJ Jr, Lee J, Ross JS, Stephens PJ, Miller VA, Ali SM, Schrock AB.

Oncologist. 2016 Nov;21(11):1306-1314. doi: 10.1634/theoncologist.2016-0148. Epub 2016 Sep 28.

47.

Preventing Catheter-Associated Urinary Tract Infections.

Saint S, Greene MT, Fakih MG.

N Engl J Med. 2016 Sep 29;375(13):1298-9. doi: 10.1056/NEJMc1609988. No abstract available.

PMID:
27682041
48.

Taking advantage of public reporting: An infection composite score to assist evaluating hospital performance for infection prevention efforts.

Fakih MG, Skierczynski B, Bufalino A, Groves C, Roberts P, Heavens M, Hendrich A, Haydar Z.

Am J Infect Control. 2016 Dec 1;44(12):1578-1581. doi: 10.1016/j.ajic.2016.06.026. Epub 2016 Sep 16.

PMID:
27645403
49.

Reliability, Validity, and Feasibility of a Computer-Based Geriatric Assessment for Older Adults With Cancer.

Hurria A, Akiba C, Kim J, Mitani D, Loscalzo M, Katheria V, Koczywas M, Pal S, Chung V, Forman S, Nathwani N, Fakih M, Karanes C, Lim D, Popplewell L, Cohen H, Canin B, Cella D, Ferrell B, Goldstein L.

J Oncol Pract. 2016 Dec;12(12):e1025-e1034. Epub 2016 Sep 30.

50.

Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity.

Ma WW, Saif MW, El-Rayes BF, Fakih MG, Cartwright TH, Posey JA, King TR, von Borstel RW, Bamat MK.

Cancer. 2017 Jan 1;123(2):345-356. doi: 10.1002/cncr.30321. Epub 2016 Sep 13.

Supplemental Content

Support Center